Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Kura Oncology
KURA
Revenue from contracts outside the scope of ASC Topic 606
Revenue from contracts outside the scope of ASC Topic 606 at other companies
Arcutis Biotherapeutics, Inc.
ARQT
$0
-100%
Harley-Davidson
HOG
$111.94M
-54.3%
General Motors
GM
$4.28B
+2.8%
Green Dot
GDOT
$27.24M
+26.0%
Intuitive Machines, Inc.
LUNR
$3.1M
—
Madison Square Garden Entertainment
MSGE
$9.01M
+6.2%
Segments
By product
See full
Development Services For Monotherapy
$28M
+5,500%
Development Services In Combination With Other Therapies
$19.3M
+2,313%
Other financials
Income statement
See full
Revenue
$18.3M
+29.5%
Gross profit
$18.0M
—
Operating income
-$78.8M
-21.8%
Net income
-$73.3M
-27.7%
EPS (diluted)
-$0.83
-25.8%
Balance sheet
See full
Cash & equivalents
$39.1M
-23.8%
Total debt
$24.3M
+25.4%
Total equity
$107.9M
-70.4%
Total assets
$652.6M
-12.3%
Cash flow
See full
Operating cash flow
-$85.9M
-19.4%
CapEx
$128.0K
-56.2%
Free cash flow
-$86.0M
-19.1%
Valuation
See full
Market cap
$919.7M
+81.6%
Enterprise value
$904.89M
+90.7%
P/S
12.8×
+3.5×
Profitability
See full
Operating margin
-443.5%
+103pp
Net margin
-411.2%
+125pp
FCF margin
130.6%
+74.1pp
Returns & leverage
See full
Return on equity
-124.7%
-252pp
Debt / equity
0.2×
+0.2×
Current ratio
6.1×
-1.9×